Personalized genetic profiles of risk and resilience in Alzheimer’s and vascular diseases
- PI
- Kulminski, Alexander
- DAR ID
- 10173
- Initial Approval Date
- August 10, 2020
- Current DAR Status
- Active
- PI Institution
- DUKE UNIVERSITY
- PI Institution Country
- United States
- PI Institution Type
- Non-Profit
Requested Datasets (8)
NG00067Alzheimer's Disease Sequencing Project Umbrella StudyNG00022ADC1 - Alzheimer's Disease Center Dataset 1NG00023ADC2 - Alzheimer's Disease Center Dataset 2NG00024ADC3 - Alzheimer's Disease Center Dataset 3NG00068ADC4 - Alzheimer's Disease Center Dataset 4NG00069ADC5 - Alzheimer's Disease Center Dataset 5NG00070ADC6 - Alzheimer's Disease Center Dataset 6NG00071ADC7 - Alzheimer's Disease Center Dataset 7
Research Use Statement
Objective: to identify personalized genetic profiles of risks and resilience to Alzheimer’s disease (AD) and vascular diseases in the disease-specific and pleiotropic contexts in prioritized loci leveraging information from the AD-centered pleiotropic meta-analysis planned in this project and previous analyses by our and other research groups, and identify the role of AD risk and other factors in these profiles using ADSP and 13 more studies. Study design: Aim 1 will identify specific and pleiotropic loci for AD and vascular traits from new analyses and the existing publications by: (i) performing pleiotropic genome-wide analysis focused on AD, cardiovascular diseases (CVD), and AD risk factors and (ii) identifying promising loci from this analysis and the results of previous analyses by our and other research groups. Aim 2 will dissect heterogeneity leveraging the analysis of molecular signatures defined as differences in linkage disequilibrium patterns in affected and unaffected subjects. Aim 3 will identify personalized genetic profiles of AD-specific and pleiotropic risks and resilience. Aim 4 will leverage biological, bioinformatics, and omics analyses to make sense of statistical inferences. In some cases, we may need to pool several datasets to increase power of the analyses in a mega sample. This will be done by pooling individuals’ records for genotypes and selected phenotypes described above from different studies. This pooling will not create any additional risks to participants because neither genetic nor phenotypic information for the same individual will increase.
This research is consistent with data use restrictions for ADSP. We will not conduct non-genetic research, will not investigate individual pedigree structures, population origins, ancestry, individual participant genotypes, perceptions of racial/ethnic identity, variables that could be considered as stigmatizing an individual or group, or issues such as non-maternity. The research is designed to protect data confidentiality and follow local and institutional policies and procedures for data handling. The results of this research will be broadly shared with the scientific community.
This research is consistent with data use restrictions for ADSP. We will not conduct non-genetic research, will not investigate individual pedigree structures, population origins, ancestry, individual participant genotypes, perceptions of racial/ethnic identity, variables that could be considered as stigmatizing an individual or group, or issues such as non-maternity. The research is designed to protect data confidentiality and follow local and institutional policies and procedures for data handling. The results of this research will be broadly shared with the scientific community.
Non-Technical Summary
Increasing population of the elderly individuals worldwide raises serious concerns about burden of geriatric conditions in future, especially Alzheimer’s disease, cardiovascular diseases, and other common aging-related diseases. These diseases can cluster in families suggesting that they can have genetic origin. Understanding their genetic origin could lead to breakthrough in preventing or curing such diseases. Despite continuing efforts, understanding their genetic basis remains very limited. Particular problem is to better understand genetic basis of Alzheimer’s disease, its relationship to other aging-related diseases, and identify genetic variants which could help protect against such diseases. This project focuses on identifying personalized genetic profiles of risk and resilience to AD and vascular diseases. This research will facilitate the development of interventional strategies aiming to promote healthy aging.
Reported Publications (7)
Publications shown are those reported by investigators through NIAGADS DAR reporting and renewal processes and may not represent a complete list of publications associated with the project.
- Complex genetic interactions affect susceptibility to Alzheimer's disease risk in the BIN1 and MS4A6A loci. Nazarian A, et al. GeroScience. 2025. PMID: 39751715
- Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles. Loika Y, et al. Alzheimer's & dementia (Amsterdam, Netherlands). 2024. PMID: 39398945
- TOMM40 and APOC1 variants differentiate the impacts of the APOE ε4 allele on Alzheimer's disease risk across sexes, ages, and ancestries. Kulminski AM, et al. Alzheimer's & dementia (Amsterdam, Netherlands). 2024. PMID: 38912305
- Inter- and intra-chromosomal modulators of the APOE ɛ2 and ɛ4 effects on the Alzheimer's disease risk. Nazarian A, et al. GeroScience. 2023. PMID: 35809216
- Interaction Analysis Reveals Complex Genetic Associations with Alzheimer's Disease in the CLU and ABCA7 Gene Regions. Nazarian A, et al. Genes. 2023. PMID: 37761806
- Genome-wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk. Nazarian A, et al. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2022. PMID: 34978151
- Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men. Kulminski AM, et al. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2021. PMID: 34310032